Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-gangster-flat-bread-pizza-mixPublished September 18, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 19, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Ongoing Historical recordClass II

Amlodipine and Valsartan Tablets, USP, 10 mg/160mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-206-30

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Amlodipine and Valsartan Tablets, USP, 5 mg/320 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-205-30

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-204-30

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 320mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-070-90

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 80mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-068-90

by Torrent Pharma Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit Dose NDC 50268-786-13 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 80 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-784-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 40 mg Rx Only NDC 50268-783-15 50 Tablets (5x10) Unit Dose Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.

by Mayne Pharma Inc

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count bottles, NDC 55289-866-06; c) 7-count bottles, NDC 55289-866-07; d) 10-count bottles, NDC 55289-866-10; e) 14-count bottles, NDC 55289-866-14; f) 20-count bottles, NDC 55289-866-20; g) 28-count bottles, NDC 55289-866-28; h) 30-count bottles, NDC 55289-866-30; i) 120-count bottles, NDC 55289-866-98; j) 300-count bottles, NDC 55289-866-87; k) 400-count bottles, NDC 55289-866-74; Rx only, Packaged By PD-Rx Pharmaceuticals, Oklahoma City, OK 73127.

by PD-Rx Pharmaceuticals, Inc.

Reason: Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Hostess Brands, LLC

Product: Hostess Brownies Cookies 'n Cr¿me packaged in the following…
Reason: The product ingredients statement declares egg ingredients, but the "Contains" statement fails to declare egg.
Published: September 5, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.

by Westminster Pharmaceuticals LLC

Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.

by Westminster Pharmaceuticals LLC

Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.

by Westminster Pharmaceuticals LLC

Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.

by Westminster Pharmaceuticals LLC

Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-156-04.

by Westminster Pharmaceuticals LLC

Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited Unit V, Pollepally Jadcherla Mahaboob Nagar - 509-301 India. NDC 31722-748-90 UPC 331722748902

by Hetero Labs Limited Unit V

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: August 29, 2018
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Pollepally Jadcherla Mahabubnagar - 509-301, India. NDC 31722-747-90 UPC 331722747905

by Hetero Labs Limited Unit V

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published: August 29, 2018
Distribution: Nationwide

View recall →

Data last updated: September 19, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.